annual CFI:
-$299.48M-$260.23M(-662.86%)Summary
- As of today (June 28, 2025), PTGX annual cash flow from investing activities is -$299.48 million, with the most recent change of -$260.23 million (-662.86%) on December 31, 2024.
- During the last 3 years, PTGX annual CFI has fallen by -$283.62 million (-1788.29%).
- PTGX annual CFI is now -427.42% below its all-time high of $91.47 million, reached on December 31, 2022.
Performance
PTGX Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$94.40M-$85.68M(-981.97%)Summary
- As of today (June 28, 2025), PTGX quarterly cash flow from investing activities is -$94.40 million, with the most recent change of -$85.68 million (-981.97%) on March 1, 2025.
- Over the past year, PTGX quarterly CFI has dropped by -$100.47 million (-1654.97%).
- PTGX quarterly CFI is now -264.82% below its all-time high of $57.27 million, reached on September 30, 2022.
Performance
PTGX quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$399.96M-$100.47M(-33.55%)Summary
- As of today (June 28, 2025), PTGX TTM cash flow from investing activities is -$399.96 million, with the most recent change of -$100.47 million (-33.55%) on March 1, 2025.
- Over the past year, PTGX TTM CFI has dropped by -$356.94 million (-829.85%).
- PTGX TTM CFI is now -446.58% below its all-time high of $115.40 million, reached on September 30, 2022.
Performance
PTGX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
PTGX Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -662.9% | -1655.0% | -829.9% |
| 3 y3 years | -1788.3% | -2009.1% | -2853.2% |
| 5 y5 years | -457.6% | -320.9% | -2550.8% |
PTGX Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -427.4% | at low | -264.8% | +54.8% | -446.6% | at low |
| 5 y | 5-year | -427.4% | at low | -264.8% | +54.8% | -446.6% | at low |
| alltime | all time | -427.4% | at low | -264.8% | +54.8% | -446.6% | at low |
PTGX Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$94.40M(+982.0%) | -$399.96M(+33.5%) |
| Dec 2024 | -$299.48M(+662.9%) | -$8.72M(-95.8%) | -$299.48M(-14.9%) |
| Sep 2024 | - | -$208.71M(+136.9%) | -$352.05M(+124.4%) |
| Jun 2024 | - | -$88.12M(-1551.5%) | -$156.89M(+264.8%) |
| Mar 2024 | - | $6.07M(-109.9%) | -$43.01M(+9.6%) |
| Dec 2023 | -$39.26M(-142.9%) | -$61.29M(+352.0%) | -$39.26M(-251.2%) |
| Sep 2023 | - | -$13.56M(-152.6%) | $25.96M(-73.2%) |
| Jun 2023 | - | $25.76M(+162.2%) | $96.80M(-8.5%) |
| Mar 2023 | - | $9.83M(+149.7%) | $105.77M(+15.6%) |
| Dec 2022 | $91.47M(-676.7%) | $3.94M(-93.1%) | $91.47M(-20.7%) |
| Sep 2022 | - | $57.27M(+64.9%) | $115.40M(+760.0%) |
| Jun 2022 | - | $34.73M(-876.0%) | $13.42M(-199.1%) |
| Mar 2022 | - | -$4.48M(-116.1%) | -$13.54M(-14.6%) |
| Dec 2021 | -$15.86M(-82.6%) | $27.87M(-162.3%) | -$15.86M(-86.6%) |
| Sep 2021 | - | -$44.71M(-675.2%) | -$118.13M(-7.4%) |
| Jun 2021 | - | $7.77M(-214.4%) | -$127.54M(-9.2%) |
| Mar 2021 | - | -$6.79M(-90.9%) | -$140.49M(+54.4%) |
| Dec 2020 | -$90.97M(+69.4%) | -$74.40M(+37.5%) | -$90.97M(+212.4%) |
| Sep 2020 | - | -$54.12M(+946.6%) | -$29.12M(+313.9%) |
| Jun 2020 | - | -$5.17M(-112.1%) | -$7.03M(-53.4%) |
| Mar 2020 | - | $42.73M(-440.4%) | -$15.09M(-71.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$53.71M(-2527.0%) | -$12.55M(-60.8%) | -$53.71M(+46.7%) |
| Sep 2019 | - | -$32.04M(+142.3%) | -$36.61M(-784.4%) |
| Jun 2019 | - | -$13.22M(-421.9%) | $5.35M(-81.0%) |
| Mar 2019 | - | $4.11M(-9.7%) | $28.16M(+1172.7%) |
| Dec 2018 | $2.21M(-86.0%) | $4.55M(-54.1%) | $2.21M(-8.4%) |
| Sep 2018 | - | $9.92M(+3.4%) | $2.42M(-129.2%) |
| Jun 2018 | - | $9.59M(-143.9%) | -$8.27M(+73.4%) |
| Mar 2018 | - | -$21.84M(-559.7%) | -$4.77M(-130.2%) |
| Dec 2017 | $15.82M(-126.7%) | $4.75M(-715.5%) | $15.82M(-129.7%) |
| Sep 2017 | - | -$772.00K(-105.9%) | -$53.25M(+9.6%) |
| Jun 2017 | - | $13.09M(-1147.4%) | -$48.60M(-28.2%) |
| Mar 2017 | - | -$1.25M(-98.1%) | -$67.72M(+14.2%) |
| Dec 2016 | -$59.33M(+617.9%) | -$64.33M(-1756.2%) | -$59.33M(+1821.2%) |
| Sep 2016 | - | $3.88M(-164.4%) | -$3.09M(-56.4%) |
| Jun 2016 | - | -$6.03M(-184.4%) | -$7.08M(+537.1%) |
| Mar 2016 | - | $7.15M(-188.4%) | -$1.11M(-86.5%) |
| Dec 2015 | -$8.26M(+2663.9%) | -$8.09M(+7054.9%) | -$8.26M(+4516.8%) |
| Sep 2015 | - | -$113.00K(+85.2%) | -$179.00K(+171.2%) |
| Jun 2015 | - | -$61.00K(+1120.0%) | -$66.00K(+1220.0%) |
| Mar 2015 | - | -$5000.00 | -$5000.00 |
| Dec 2014 | -$299.00K | - | - |
FAQ
- What is Protagonist Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual CFI year-on-year change?
- What is Protagonist Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly CFI year-on-year change?
- What is Protagonist Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Protagonist Therapeutics?
- What is Protagonist Therapeutics TTM CFI year-on-year change?
What is Protagonist Therapeutics annual cash flow from investing activities?
The current annual CFI of PTGX is -$299.48M
What is the all time high annual CFI for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual cash flow from investing activities is $91.47M
What is Protagonist Therapeutics annual CFI year-on-year change?
Over the past year, PTGX annual cash flow from investing activities has changed by -$260.23M (-662.86%)
What is Protagonist Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of PTGX is -$94.40M
What is the all time high quarterly CFI for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly cash flow from investing activities is $57.27M
What is Protagonist Therapeutics quarterly CFI year-on-year change?
Over the past year, PTGX quarterly cash flow from investing activities has changed by -$100.47M (-1654.97%)
What is Protagonist Therapeutics TTM cash flow from investing activities?
The current TTM CFI of PTGX is -$399.96M
What is the all time high TTM CFI for Protagonist Therapeutics?
Protagonist Therapeutics all-time high TTM cash flow from investing activities is $115.40M
What is Protagonist Therapeutics TTM CFI year-on-year change?
Over the past year, PTGX TTM cash flow from investing activities has changed by -$356.94M (-829.85%)